Ipca Laboratories Ltd share price logo

Ipca Laboratories Share Price

NSE: IPCALAB

BSE: 524494

Mid Cap

Healthcare Sector

₹1485.40

+12.50

(+0.85%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Ipca Laboratories Stock Performance

as on February 13, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹1,428.80
    ₹1,503.90
    downward going graph

    3.81%

    Downside

    1.25%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹1,168.20
    ₹1,595.00
    downward going graph

    21.35%

    Downside

    7.38%

    Upside

    downward going graph

Ipca Laboratories share price movements today

Previous Close
₹1,472.90
Open
₹1,458.00
Volume
4.08L
Upper Circuit
₹1,767.40
Lower Circuit
₹1,178.40
Day's Low - High
₹1,428.80 - ₹1,503.90
52 Week Low - High
₹1,168.20 - ₹1,595.00

Ipca Laboratories Historical Returns

1 Month Return
-1.62 %
3 Month Return
+ 1.41 %
1 Year Return
+ 0.59 %
3 Year Return
+ 76.09 %
5 Year Return
+ 56.66 %

Ipca Laboratories Fundamentals

as on February 13, 2026 at 4:01 pm IST

Market Cap

₹37,685.22 Cr

Return on Equity (ROE)

12.39

PE Ratio (TTM)

41.42

Return on capital employed (ROCE)

17.21

Industry PE ratio

41.52

Beta (LTM)

0.7

P/B Ratio

5.53

Dividend Yield

0.27

PEG Ratio

5.83

Quarterly Earnings Growth YOY

31.27

EPS (TTM)

31.04

Sector

Pharmaceuticals

Book Value

273.88

Technical Analysis

Bullish

View Technical Analysis

Ipca Laboratories Stock Valuation

as on February 13, 2026 at 4:01 pm IST

Ipca Laboratories in the last 5 years

  • Overview

  • Trends

Lowest (18.72x)

October 10, 2019

Today (41.42x)

February 13, 2026

Industry (41.52x)

February 13, 2026

Highest (65.89x)

September 25, 2024

LowHigh

Today’s Price to Earnings Ratio: 41.42x

Ipca Laboratories Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Ipca Laboratories with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Ipca Laboratories Ltd image
Ipca Laboratories Ltd
BUY37,685.2211.33%0.657878,939
Sanofi India Ltd image
Sanofi India Ltd
BUY9,296.75-9.71%0.524132,013
Aurobindo Pharma Ltd image
Aurobindo Pharma Ltd
BUY66,536.634.58%0.603,48331,723
Zydus Lifesciences Ltd image
Zydus Lifesciences Ltd
HOLD91,033.9918.75%0.614,61423,241
Abbott India Ltd image
Abbott India Ltd
BUY56,227.5016.63%0.001,4146,445
See all

Analyst Recommendation on Ipca Laboratories Stock

Based on 14 analysts

BUY

78.57%

Buy

14.29%

Hold

7.14%

Sell

Based on 14 analysts, 78.57% of analysts recommend a 'BUY' rating for Ipca Laboratories. Average target price of ₹1600

Source: S&P Global Market Intelligence

Ipca Laboratories Share Price Target

Get share price movements and forecasts by analysts on Ipca Laboratories.

What analysts predicted

7.72%UPSIDE

Target Price

₹1600

Current Price

₹1485.4

Analyzed by

14 Analysts

High

₹1730

Target

₹1600.00

Low

₹1350

Ipca Laboratories target price ₹1600, a slight upside of 7.72% compared to current price of ₹1485.4. According to 14 analysts rating.

Source: S&P Global Market Intelligence

Ipca Laboratories Stock’s Investor Sentiment and Interest

Search interest for Ipca Laboratories Ltd Stock has decreased by -3% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-3% versus previous 30 day period

Ipca Laboratories Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
1,511.63
1,585.21
2,033.96
2,052.85
2,033.03
2,092.63
2,354.9
2,245.37
2,246.69
2,308.85
2,556.5
2,392.5
Other Income
36.39
44.85
38.55
90.91
18.92
20.61
26.26
20.11
25.82
32.66
27.86
37.84
Total Income
1,548.02
1,630.06
2,072.51
2,143.76
2,051.95
2,113.24
2,381.16
2,265.48
2,272.51
2,341.51
2,584.36
2,430.34
Expenses
1,330.59
1,277.59
1,712.69
1,721.97
1,847.85
1,699.91
1,913.42
1,782.29
2,022.88
1,892.43
2,069.84
1,859.15
Operating Profit
181.04
307.62
321.27
330.88
185.18
392.72
441.48
463.08
223.81
416.42
486.66
533.35
Operating Profit Margin %
11.98%
19.41%
15.8%
16.12%
9.11%
18.77%
18.75%
20.62%
9.96%
18.04%
19.04%
22.29%
Profit Before Interest, Tax and Depreciation
217.43
352.47
359.82
421.79
204.1
413.33
467.74
483.19
249.63
449.08
514.52
571.19
Interest
18.45
31.38
44.12
33.4
29.37
24.05
22.56
16.81
21.51
18.51
19.61
17.62
Depreciation
69.54
69.27
90.34
99.5
98.13
98.89
100.35
98.46
100.12
100.06
103.33
107.59
Profit Before Tax
129.44
251.82
225.36
288.89
76.6
290.39
344.83
367.92
128
330.51
391.58
445.98
Tax Paid
48.37
85.61
87.92
66.24
73.69
91.41
99.39
90.59
62.22
96.09
108.08
81.93
Profit After Tax
81.07
166.21
137.44
222.65
2.91
198.98
245.44
277.33
65.78
234.42
283.5
364.05
Total Net profit including share of profit / Loss from associate company
78.14
164.1
136.49
221
1.33
199.14
245.75
276.36
63.99
232.89
280.53
363.67
EPS
3.02
6.42
5.72
7.09
2.35
7.58
9.05
9.78
2.67
9.19
11.14
12.86
Actual EPS
3.02
6.42
5.72
7.09
2.35
7.58
9.05
9.78
2.67
9.19
11.14
12.86
Adjusted EPS
3.02
6.42
5.72
7.09
2.35
7.58
9.05
9.78
2.67
9.19
11.14
12.86
Diluted EPS
3.02
6.42
5.72
7.09
2.35
7.58
9.05
9.78
2.67
9.19
11.14
12.86

Ipca Laboratories Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
3,212.2
3,283.57
3,773.18
4,648.71
5,419.99
5,829.79
6,244.32
7,705.04
8,939.59
Other Income
21.01
41.8
57.68
67
62.84
66.57
125.62
124.77
92.8
Total Income
3,233.21
3,325.37
3,830.86
4,715.71
5,482.83
5,896.36
6,369.94
7,829.81
9,032.39
Expenses
2,774.12
2,833.09
3,083.11
3,749.82
3,875.64
4,520.53
5,317.55
6,491.63
7,418.5
Operating Profit
438.08
450.48
690.07
898.89
1,544.35
1,309.26
926.77
1,213.41
1,521.09
Operating Profit Margin %
13.64%
13.72%
18.29%
19.34%
28.49%
22.46%
14.84%
15.75%
17.02%
Profit Before Interest, Tax and Depreciation
459.09
492.28
747.75
965.89
1,607.19
1,375.83
1,052.39
1,338.18
1,613.89
Interest
24.08
24.02
18.87
16.5
9.04
7.69
45.54
138.27
84.93
Depreciation
172.95
177.73
182.42
210.5
209.17
232.42
261.56
357.24
397.82
Profit Before Tax
262.06
290.53
546.46
738.89
1,388.98
1,135.72
745.29
842.67
1,131.14
Tax Paid
67.52
51.11
104.24
135.33
240.14
224.77
253.36
313.46
343.61
Profit After Tax
194.54
239.42
442.22
603.56
1,148.84
910.95
491.93
529.21
787.53
Total Net profit including share of profit / Loss from associate company
194.54
239.42
442.22
603.56
1,141.14
889.79
478.99
522.92
785.24
EPS
15.42
18.97
35.01
47.77
90.02
34.85
18.58
21.57
29.08
Actual EPS
15.42
18.97
35.01
47.77
90.02
34.85
18.58
21.57
29.08
Adjusted EPS
7.71
9.49
17.51
23.89
45.01
34.85
18.58
21.57
29.08
Diluted EPS
15.42
18.97
35.01
47.73
90.02
34.85
18.58
21.57
29.08

Ipca Laboratories Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
708.65
281.91
341.13
501.03
570.35
1,090.13
856.07
805.81
944.65
1,321.32
Cash Flow from Investing Activities
-223.69
-145.42
-135.4
-179.92
-509.34
-520.69
-850.93
-725
-1,215.29
-869.5
Cash Flow from Financing Activities
-456.51
-154.13
-125.41
-183.2
-136.54
-305.82
426.78
507.24
-552.55
-282.98
Net Cash Flow
28.81
-26.04
75.32
152.77
-75.53
263.62
431.92
588.05
-823.19
168.84

Ipca Laboratories Stock Shareholding Pattern

Numbers in percentages

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
46.29%
46.29%
46.29%
46.29%
46.3%
46.3%
46.3%
44.72%
44.72%
44.72%
44.72%
44.72%
DII
33.55%
35.19%
35.05%
33.79%
34.37%
33.78%
34.23%
35.68%
36.06%
36.2%
36.77%
37.32%
FII
0.02%
0%
9.86%
0%
10.51%
10.85%
10.83%
11.07%
10.76%
10.67%
10.43%
10.63%
Public
9.07%
8.48%
8.81%
8.92%
8.82%
9.06%
8.64%
8.53%
8.46%
8.41%
8.07%
7.33%
Total Outstanding Shares
25,37,04,218
25,37,04,218
25,37,04,218
25,37,04,218
25,37,04,218
25,37,04,218
25,37,04,218
25,37,04,218
25,37,04,218
25,37,04,218
25,37,04,218
25,37,04,218
Total Shareholders
1,10,296
99,889
95,930
82,809
81,165
84,753
82,975
90,189
88,306
85,582
82,870
77,673

Mutual Funds that own Ipca Laboratories Stock

Check out the Mutual Funds with significant holdings in Ipca Laboratories.

Ipca Laboratories Corporate Actions

View detailed summary of the earnings and dividend history of Ipca Laboratories.

  • Ipca Laboratories Ltd Earnings Results

    Ipca Laboratories Ltd’s net profit jumped 31.49% since last year same period to ₹326.27Cr in the Q3 2025-2026. On a quarterly growth basis, Ipca Laboratories Ltd has generated 15.47% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Ipca Laboratories Ltd Dividends May,2025

    In the quarter ending March 2025, Ipca Laboratories Ltd has declared dividend of ₹2.00 per share on 29 May 2025 - translating a dividend yield of 0.40%.

    Read More about Dividends

Indices Featuring Ipca Laboratories Stock

Check stock indices that include Ipca Laboratories.

NIFTY PHARMA

₹22,194.90

-0.85 (▲191.40%)

S&P BSE 150 MidCap

₹16,030.52

-1.58 (▲257.50%)

Nifty MidSmallcap 400

₹19,694.05

-1.64 (▲328.30%)

BSE Healthcare

₹42,636.95

-1.05 (▲450.77%)

Nifty 500

₹23,313.15

-1.43 (▲338.40%)

S&P BSE 400 MidSmallCap

₹11,755.94

-1.56 (▲185.70%)

Nifty LargeMidcap 250

₹16,518.00

-1.50 (▲251.60%)

Nifty Healthcare

₹14,384.05

-0.85 (▲123.00%)

Nifty Midcap 150

₹21,884.35

-1.65 (▲368.05%)

S&P BSE 250 LargeMidCap

₹10,944.82

-1.38 (▲153.68%)

BSE 500

₹36,532.48

-1.40 (▲516.92%)

Insights on Ipca Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 10.42% to 10.63% in Dec 2025 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, IPCALAB stock has moved up by 2.3%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, 67.82 Cr → 326.27 Cr (in ₹), with an average increase of 33.9% per quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 30.04% to 30.52% in Dec 2025 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 44.72% of holdings in Dec 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 169.7% return, outperforming this stock by 93.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 32.5% return, outperforming this stock by 31.9%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 2.58K Cr → 2.43K Cr (in ₹), with an average decrease of 6.0% per quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 8.07% to 7.33% in Dec 2025 quarter

About Ipca Laboratories Ltd

Ipca Laboratories is a fully integrated global pharmaceutical company, manufacturing and marketing over 350 formulations and 80 APIs in over 100 countries around the world. Established in 1949, with its original name as Indian Pharmaceutical Combine Association Limited, Ipca has 17 manufacturing units in India, producing APIs and Formulations that are approved by major drug regulatory authorities, including the US FDA, UK MHRA, South African MCC, Brazilian ANVISA and Australian TGA. Apart from native India, Ipca is also a recognized supplier of intermediates and APIs⁠—Atenolol, Chloroquine Phosphate, Furosemide, and Pyrantel Salts⁠—globally. Ipca has received accreditation from ISO 9001, Forbes Global 200 best small companies, WHOGMP, INVIMA Colombian, and German standards, making it a respected name in the pharmaceutical industry. Recently, Ipca has acquired a number of companies, namely Krebs Biochemicals and Industries Ltd., Pisgah Labs Inc., Trophic Wellness Private Ltd, Lyka Labs Limited, and M/s. Ramdev Chemical Private Limited, to further extend its presence in the global market.

Revenue: ₹2,392.50Cr as on December 2025 (Q3 FY26)
Net Profit: ₹364.05Cr as on December 2025 (Q3 FY26)
Listing date: 03 Nov, 1994
Chairperson Name: Premchand Godha
OrganisationIpca Laboratories Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOPremchand Godha
E-voting on sharesClick here to vote

FAQs

What is Ipca Laboratories share price today?

Ipca Laboratories share price today stands at ₹1485.4 as on at the close of the market. Ipca Laboratories share today touched a day high of ₹1503.9 and a low of ₹1428.8.

What is the 52 week high and 52 week low range for Ipca Laboratories share?

Ipca Laboratories touched a 52 week high of ₹1595 and a 52 week low of ₹1168.2. Ipca Laboratories share price today i.e. is closed at ₹1485.4, which is -6.87% down from its 52 week high and 27.15% up from its 52 week low.

What is Ipca Laboratories's market capitalisation today?

Ipca Laboratories market capitalisation is ₹37,685.22 Cr as on .

How to buy Ipca Laboratories shares?

To buy Ipca Laboratories shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for IPCALAB or Ipca Laboratories Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Ipca Laboratories shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Ipca Laboratories trading volume today?

Ipca Laboratories trading volume is 4.08L as on . This means that 4.08L shares of Ipca Laboratories were bought and sold on the stock market during today's trading session.